DBV Technologies to Participate in Upcoming Investor Conference
September 05 2023 - 4:30PM
Montrouge, France, September 5, 2023
DBV
Technologies to
Participate in Upcoming Investor Conference
DBV Technologies (Euronext: DBV – ISIN:
FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage
biopharmaceutical company, today announced the company will
participate in the H.C. Wainwright Annual Global Investment
Conference taking place on September 11th −13th in New York, NY.
Daniel Tassé, Chief Executive Officer, will represent the company
in a fireside chat session on Tuesday, September 12th at 4:00 pm
EST, as well as one-on-one investor meetings throughout the
day.
A live webcast of the presentation will be
available on the Investors & Media section of the Company’s
website:
https://journey.ct.events/view/4f45c9c0-d6f0-4fe2-a5b2-ffc6be420349.
A replay will also be available on DBV
Technologies’ website for 90 days after the event.
About DBV TechnologiesDBV
Technologies is developing Viaskin™, an investigational proprietary
technology platform with broad potential applications in
immunotherapy. Viaskin is based on epicutaneous immunotherapy, or
EPIT™, and is DBV Technologies’ method of delivering biologically
active compounds to the immune system through intact skin. With
this new class of non-invasive product candidates, the Company is
dedicated to safely transforming the care of food allergic
patients. DBV Technologies’ food allergies programs include ongoing
clinical trials of Viaskin Peanut. DBV Technologies has global
headquarters in Montrouge, France, and North American operations in
Basking Ridge, NJ. The Company’s ordinary shares are traded on
segment B of Euronext Paris (Ticker: DBV, ISIN code: FR0010417345)
and the Company’s ADSs (each representing one-half of one ordinary
share) are traded on the Nasdaq Global Select Market (Ticker:
DBVT).
Investor Contact Katie
MatthewsDBV
Technologies+1 857-529-2563katie.matthews@dbv-technologies.com
Media ContactAngela MarcucciDBV
Technologies+1 646-842-2393 angela.marcucci@dbv-technologies.com
Viaskin and EPIT are trademarks of DBV
Technologies.
DBV Technologies (NASDAQ:DBVT)
Historical Stock Chart
From Apr 2024 to May 2024
DBV Technologies (NASDAQ:DBVT)
Historical Stock Chart
From May 2023 to May 2024